documents: FDA-2022-D-0814-0003
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2022-D-0814-0003 | FDA | FDA-2022-D-0814 | Infant Formula Transition Plan for Exercise of Enforcement Discretion: Guidance for Industry | Other | Guidance | 2022-10-06T04:00:00Z | 2022 | 10 | 2022-10-06T04:00:00Z | 2022-11-08T04:59:59Z | 2024-11-07T00:43:08Z | 1 | 0 | 09000064853c9b9a |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref